indian drug major sun pharma hit ban import products made karkhadi
plant gujarat us food drug administration due violation manufacturing norms
according information available usfda website regulator issued import alert enables detention without physical examination drugs firms met drug gmps good manufacturing practices
comments company could obtained immediately
first import alert sun pharmas plants usfda cracking heavily firms ranbaxy wockhardt complied manufacturing norms
plants ranbaxy india banned exporting drugs us wockhardt also faced similar actions two plants india
per sun pharmaceutical industries website karkhadi plant manufactures active pharmaceutical ingredients formulations company 10 manufacturing sites india
earlier week company voluntarily recalled 2528 bottles generic version diabetes drug glumetza us market basis customer complaint found bottles glumetza contained medicines treat epilepsy
sun pharma scrip tanked 397 per cent previous close afternoon trade quoting rs 580 bse
